Metabolic syndrome, and not obesity, is associated with chronic kidney disease
American Journal of Nephrology Sep 21, 2021
Ciardullo S, Ballabeni C, Trevisan R, et al. - This large cross-sectional study reveals that metabolic syndrome (MS) rather than obesity is linked to kidney damage and that the obese participants without MS (OB+ MS−) phenotype does not appear to be related to an elevated risk of kidney disease.
All adult individuals (n = 12,335) with available data on BMI, estimated glomerular filtration rate (eGFR), urine albumin to creatinine ratio (UACR), and each MS component were included in the study.
OB+ MS− were younger and more often female.
After adjustment for potential confounders, compared with OB− MS− participants, both OB− MS+ groups and the OB+ MS+ groups had a greater prevalence of albuminuria and a lower eGFR, but not the OB+ MS− groups.
When each of the MS components was examined separately, raised blood pressure and low high-density lipoprotein cholesterol were correlated with both UACR and lower eGFR, whereas elevated blood glucose and triglycerides were related to only UACR.
Waist circumference was not related to any of the renal outcomes studied.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries